Status and phase
Conditions
Treatments
About
The objective of this trial to see whether:
-Cardiac performance (cardiac index and secondary outcomes)can be improved in patients with acute heart failure (AHF) and symptoms and consequences of fluid overload (pulmonary and interstitial edema) and poor peripheral perfusion can be reduced by:
Optimal standard treatment will be achieved in both arms with the use of current best treatment protocol for AHF as per independent treating physician.
To assess effects of 0.5M Na lactate (Totilac) on plasma and urine biological parameters (sodium, potassium, chloride, pH, bicarb, base excess, albumin)
To assess effects of 0.5M Na lactate on morbidity and mortality.
Full description
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Left heart failure: as evidenced by 2 out of 3:
Right heart failure: as evidenced by 1 out of 2:
Cold mottled skin Low urine output Acutely clouded sensorium/poor mentation
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
41 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal